- Jiang M, Ding H, Huang YH, Lau CW, Guo Y, Luo J, Shih YT, Xia Y, Yao X, Chiu JJ, Wang L, Chien S, Huang Y (2025) Endothelial serotonin receptor 1B acts as a mechanosensor to drive atherosclerosis. Circulation Research 2025 Mar 12. doi: 10.1161/CIRCRESAHA.124.325453. Online ahead of print.
-
Ding H, Jiang M, Chan AM, Xia Y, Ma RCW, Yao X, Wang L, Huang Y (2024) Targeting endothelial Src attenuates disturbed flow-induced inflammation and atherogenesis. British Journal of Pharmacology (Accepted)
- Jiang M, Ding H, Huang Y, Cheng CK, Lau CW, Xia Y, Yao X, Wang L, Huang Y (2023) Thioridazine protects against disturbed flow-induced atherosclerosis by inhibiting RhoA/YAP-mediated endothelial inflammation. Acta Pharmacologica Sinica 44(10):1977-1988.
- Cheng CK, Ding H, Jiang M, Yin H, Gollasch M, Huang Y (2023) Perivascular adipose tissue: Fine-tuner of vascular redox status and inflammation. Redox Biology 62:102683.
- Ding H, Jiang M, Lau CW, Luo J, Chan AM, Wang L, Huang Y (2023) Curaxin CBL0137 inhibits endothelial inflammation and atherogenesis via suppression of Src-YAP signaling axis. British Journal of Pharmacology 180(8):1168-1185. (Co-first author)
- Jiang M, Ding H, Huang Y & Wang L (2022) Shear Stress and Metabolic Disorders-Two Sides of the Same Plaque. Antioxidants & Redox Signaling 37(10-12): 820-841.
|
